Unlocking an Affordable Future: Key #1 Ensure System Sustainability ENSURE SYSTEM SUSTAINABILITY BY PROMOTING COMPETITION A competitive private market is the best way to manage drug costs. Interventions should be focused on fixing specific market failures or gaps rather than
As the debate on high-cost prescription drugs continues and policymakers seek solutions to reduce out-of-control prices for consumers, the Pharmaceutical Care Management Association (PCMA) today is announcing the launch of a new, multi-faceted digital public affairs campaign OnYourRxSide. The campaign is designed
PCMA President and CEO Testifying Today on Importance of Preserving Employer Choice and Contracting Flexibility (Washington, D.C.) — The Pharmaceutical Care Management Association (PCMA) released the following statement today ahead of JC Scott, President and CEO of PCMA, testifying before
PBMs: Committed to Helping Patients The Critical Path Forward: Rx Policies to Reduce Patient Costs, Improve Access For America’s pharmacy benefit managers, PBMs, our core mission is to increase access to affordable prescription drugs for all Americans. But more can
The Medicare Prescription Drug Rebate Rule PCMA Urges Congress to Permanently Repeal Rebate Rule This Year The Medicare Part D prescription drug benefit provides our nation’s seniors with affordable drug coverage, which is more important now than ever. The rebate
Recently, several of the largest pharmaceutical manufacturers explained how pharmacy benefit managers (PBMs) are lowering prescription drug costs, specifically the highly priced GLP-1 weight loss drugs. Billions of dollars in direct-to-consumer and direct-to-physician advertising spending by drug companies have contributed
A former U.S. Senator, a former Secretary of State, academics, national organizations, and two current FTC commissioners raised serious concerns about the Federal Trade Commission’s (FTC) interim report on pharmacy benefit managers (PBMs). The interim report conspicuously lacks empirical data
(Washington, D.C.) — The Pharmaceutical Care Management Association issued the following statement on today’s announcement by the Administration to reduce prescription drug costs in Medicare Part B. “Today’s announcement by the Administration to include greater use of PBM tools in
(Washington, D.C.) — Pharmaceutical Care Management Association (PCMA) President and CEO JC Scott issued the following statement on the Federal Trade Commission (FTC) interim report on pharmacy benefit managers (PBMs): “Today’s interim FTC report falls far short of being a
©2024 PCMA. All Rights Reserved.
